Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6235-6244

  Flint, Mike ^a   Maidens, Catherine ^a   Loomis Price, Larry D ^b   Shotton, Christine ^a   Dubuisson, Jean ^c   Monk, Peter ^d   Higginbottom, Adrian ^d   Levy, Shoshana ^e   Mckeating, Jane A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c INSTITUT DE BIOLOGIE DE LILLE   (France)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; CELL RECEPTOR; EPITOPE; VIRUS GLYCOPROTEIN;

AMINO ACID COMPOSITION; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL AGGREGATION; CELL FUNCTION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STRAIN COS1; CELL SURFACE; CONTROLLED STUDY; DAUDI CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LYMPHOID CELL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; VIRUS CHARACTERIZATION;

EID: 0032768960     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6235-6244.1999     Document Type: Article

References (38)

1. Andria, M. L., and S. Levy. Unpublished data.
2. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149:2841-2850.
3. Chen, Y. P., T. Maguire, R. E. Hileman, J. R. Fromm, J. D. Esko, R. J. Linhardt, and R. M. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-871.
4. Choukhi, A., S. Ung, C. Wychowski, and J. Dubuisson. 1998. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. J. Virol. 72:3851-3858.
5. Cocquerel, L., J. C. Meunier, A. Pillez, C. Wychowski, and J. Dubuisson. 1998. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J. Virol. 72:2183-2191.
6. Deleersnyder, V., A. Pillez, C. Wychowski, K. Blight, J. Xu, Y. S. Hahn, C. M. Rice, and J. Dubuisson. 1997. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71:697-704.
7. Denisova, G., D. Raviv, I. Mondor, Q. J. Sattentau, and J. M. Gershoni. 1997. Conformational transitions in CD4 due to complexation with HIV envelope glycoprotein gp120. J. Immunol. 158:1157-1164.
8. Dubuisson, J., H. H. Hsu, R. C. Cheung, H. B. Greenberg, D. G. Russell, and C. M. Rice. 1994. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J. Virol. 68:6147-6160.
9. Escola, J. M., M. J. Kleijmeer, W. Stoorvogel, J. M. Griffith, O. Yoshie, and H. J. Geuze. 1998. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273:20121-20127.
10. Flint, M. Unpublished data.
11. Flint, M., J. M. Thomas, C. Maidens, C. Shotton, S. Levy, W. Barclay, and J. A. McKeating. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J. Virol., in press.
12. Guirakhoo, F., R. A. Bolin, and J. T. Roehrig. 1992. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology 191:921-931.
13. Guirakhoo, F., F. X. Heinz, and C. Kunz. 1989. Epitope model of tick borne encephalitis virus envelope glycoprotein E - analysis of structural properties, role of carbohydrate side-chain, and conformational changes occurring at acidic pH. Virology 169:90-99.
14. Higginbottom, A., et al. Unpublished data.
15. Horvath, G., V. Serru, D. Clay, M. Billard, C. Boucheix, and E. Rubinstein. 1998. CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. J. Biol. Chem. 273:30537-30543.
16. Imai, T., and O. Yoshie. 1993. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T-Cell leukemia virus type-1 are both members of the transmembrane-4 superfamily and associate with each other and with CD4 or CD8 in T cells. J. Immunol. 151:6470-6481.
17. Kimura, T., and A. Ohyama. 1988. Association between the pH-dependent conformational change of West Nile flavivirus E-protein and virus mediated membrane fusion. J. Gen. Virol. 69:1247-1254.
18. Lagging, L. M., K. Meyer, R. J. Owens, and R. Ray. 1998. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J. Virol. 72:3539-3546.
19. Levy, S., S. C. Todd, and H. T. Maecker. 1998. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16:89-109.
20. Matsuura, Y., T. Suzuki, R. Suzuki, M. Sato, H. Aizaki, I. Saito, and T. Miyamura. 1994. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology 205:141-150.
21. McKeating, J. A. Unpublished data.
22. Michalak, J. P., C. Wychowski, A. Choukhi, J. C. Meunier, S. Ung, C. M. Rice, and J. Dubuisson. 1997. Characterization of truncated forms of hepatitis C virus glycoproteins. J. Gen. Virol. 78:2299-2306.
23. Murphy, F. A. 1980. Togavirus morphology and morphogenesis, p. 241-316. In R. W. Schlesinger (ed.), The togaviruses: biology, structure, replication. Academic Press, New York, N.Y.
24. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:5701-5707.
25. Palmer, C., P. Balfe, D. Fox, J. C. May, R. Frederiksson, E. M. Fenyo, and J. A. McKeating. 1996. Functional characterization of the V1V2 region of human immunodeficiency virus type 1. Virology 220:436-449.
26. Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941.
27. Ralston, R., K. Thudium, K. Berger, C. Kuo, B. Gervase, J. Hall, M. Selby, G. Kuo, M. Houghton, and Q. L. Choo. 1993. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J. Virol. 67:6753-6761.
28. Rice, C. M. 1996. Flaviviridae: the viruses and their replication, p. 931-959. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
29. Roehrig, J. T., A. J. Johnson, A. R. Hunt, R. A. Bolin, and M. C. Chu. 1990. Antibodies to dengue 2 virus E glycoprotein synthetic peptides identify antigenic conformation. Virology 177:668-675.
30. Rosa, D., S. Campagnoli, C. Moretto, E. Guenzi, L. Cousens, M. Chin, C. Dong, A. J. Weiner, J. Y. N. Lau, Q. L. Choo, D. Chien, P. Pileri, M. Houghton, and S. Abrignani. 1996. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA 93:1759-1763.
31. Rubinstein, E., V. PoindessousJazat, F. LeNaour, M. Billard, and C. Boucheix. 1997. CD9, but not other tetraspans, associates with the beta 1 integrin precursor. Eur. J. Immunol. 27:1919-1927.
32. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
33. Selby, M. J., E. Glazer, F. Masiarz, and M. Houghton. 1994. Complex processing and protein-protein interactions in the E2-NS2 Region of HCV. Virology 204:114-122.
34. Shotton, C. Unpublished data.
35. Shotton, C., C. Arnold, Q. Sattentau, J. Sodroski, and J. A. McKeating. 1995. Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 69:222-230.
36. Smith, D. A., P. N. Monk, and L. J. Partridge. 1995. Antibodies against human CD63 activate transfected rat basophilic leukemia (RBL-2H3) cells. Mol. Immunol. 32:1339-1344.
37. Spaete, R. R., D. Alexander, M. E. Rugroden, Q. L. Choo, K. Berger, K. Crawford, C. Kuo, S. Leng, C. Lee, R. Ralston, K. Thudium, J. W. Tung, G. Kuo, and M. Houghton. 1992. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 188:819-830.
38. Takahashi, S., C. Doss, S. Levy, and R. Levy. 1990. TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J. Immunol. 145:2207-2213.